Myocyte loss in chronic heart failure

Area of Science:

• Cardiology
• Pathology
• Cell Biology

Background:

• Established heart failure is characterized by progressive left ventricular dysfunction.
• The precise mechanisms and extent of myocyte loss in chronic heart failure remain incompletely understood.

Purpose of the Study:

• To investigate progressive myocyte loss in established heart failure.
• To determine if myocyte loss occurs via necrosis or apoptosis.
• To compare myocyte loss in ischaemic heart disease versus idiopathic dilated cardiomyopathy.

Main Methods:

• Analysis of cardiac tissue from patients undergoing transplantation for end-stage heart disease.
• Utilized TUNEL method for in situ detection of apoptotic nuclei.
• Employed immunohistochemistry for specific cell markers (CD120a, CD120b, CD95, perforin, granzyme B) and C9 complex binding.
• Assessed lipofuscin deposition in macrophages and examined interstitial immune cells.

Main Results:

• Confirmed low-grade myocyte loss in chronic heart failure.
• Observed significant patient-to-patient variability in myocyte loss within disease categories.
• Found no significant difference in myocyte loss between ischaemic heart disease and idiopathic dilated cardiomyopathy.
• Identified both necrosis and apoptosis as contributors to myocyte loss.

Conclusions:

• Myocyte loss is a feature of chronic heart failure, irrespective of the underlying aetiology.
• Mechanisms driving myocyte loss appear common to both major heart failure disease groups.
• The significant patient variation suggests individual factors influence myocyte loss progression.